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Abstract
Background: Smoking remains a major public health problem; developing effective interventions
to encourage more quit attempts, and to improve the success rate of self-quit attempts, is essential
to reduce the numbers of people who smoke. Interventions for smoking cessation can be
characterised in two extremes: the intensive face-to face therapy of the clinical approach, and large-
scale, public health interventions and policy initiatives. Computer-based systems offer a method for
generating highly tailored behavioural feedback letters, and can bridge the gap between these two
extremes. Proactive mailing and recruitment can also serve as a prompt to motivate smokers to
make quit attempts or to seek more intensive help. The aim of this study is to evaluate the effect
of personally tailored feedback reports, sent to smokers identified from general practitioners lists
on quit rates and quitting activity. The trial uses a modified version of a computer-based system
developed by two of the authors to generate individually tailored feedback reports.
Method: A random sample of cigarette smokers, aged between 18 and 65, identified from GP
records at a representative selection of practices registered with the GPRF are sent a
questionnaire. Smokers returning the questionnaire are randomly allocated to a control group to
receive usual care and standard information, or to an intervention group to receive usual care and
standard information plus tailored feedback reports. Smoking status and cognitive change will be
assessed by postal questionnaire at 6-months.
Discussion: Computer tailored personal feedback, adapted to reading levels and motivation to
quit, is a simple and inexpensive intervention which could be widely replicated and delivered cost
effectively to a large proportion of the smoking population. Given its recruitment potential, a
modest success rate could have a large effect on public health. The intervention also fits into the
broader scope of tobacco control, by prompting more quit attempts, and increasing referrals to
specialised services. The provision of this option to smokers in primary care can complement
existing services, and work synergistically with other measures to produce more quitters and
reduce the prevalence of smoking in the UK.
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Background
Smoking remains a major public health problem; 23% of
all deaths in middle age are attributed to smoking [1].
Mortality from tobacco in the first half of the 21st century
will be affected much more by the number of adult smok-
ers who stop than by the number of adolescents who start
[2]. Declines in smoking rates have been greater among
the better educated, leading to a strong socio-economic
gradient in smoking prevalence [3] contributing to health
inequalities and accounting for over half of the difference
in risk of premature death between the social classes [4].
Developing effective interventions to encourage more
quit attempts, and to improve the success rate of self-quit
attempts, is essential to reduce the numbers of people
who smoke, and to reach the Department of Health's tar-
gets to reduce the prevalence of smoking in manual
groups from 32% to 26% over the next eight years [5].
Smoking cessation services are currently high on the NHS
agenda, with strong drive to deliver a variety of interven-
tions in primary care. Interventions for smoking cessation
can be characterised in two extremes. The treatment
model of the NHS services is based on the clinical
approach, offering intensive support and focusing on
individual face-to-face treatment. As a result of govern-
ment initiatives [6], the number of specialist clinics offer-
ing intensive face-to-face treatment for smoking cessation,
which can produce relatively high abstinence rates, has
increased. However, they are limited by low participation
rates, less than 2% of smokers make use of these specialist
services [7-9]. At the other extreme are large-scale, public
health interventions and policy initiatives (e.g. legislation
to control smoking in public places). This type of inter-
vention can reach large numbers of smokers, but effective-
ness rates are low partly because such interventions lack
the personal element that is central to the success rates of
the clinical approach. Computer-based systems offer a
method for generating highly tailored behavioural feed-
back letters [10], which can be cost-effectively produced
on a large scale, with the potential to help a greater pro-
portion of the smoking population in changing their
behaviour. The majority of smokers prefer less intensive
methods [11] and tailored self-help materials can bridge
the gap between these two extremes, combining the
behavioural intervention principles used in clinical inter-
ventions with the participation rates of public health
interventions. Furthermore, as many as 70% of smokers
have no serious intentions to attempt to quit in the next
year [12,13]. Proactive mailing and recruitment outside
the general practice offering personalised service, as an
alternative or addition to brief intervention delivered by
GPs, could also increase the impact of legislation, by serv-
ing as a prompt to motivate smokers to make quit
attempts or to seek more intensive help through NHS
services.
A large number of studies of tailored feedback have been
published demonstrating positive results. This trial uses a
modified version of a computer-based system developed
by two of the authors (HG and SS) to generate individu-
ally tailored feedback reports designed to encourage and
help smokers to quit. The smoker first completes a paper-
based Smoking Behaviour Questionnaire (SBQ). The SBQ
data are scanned into a database, and the computer pro-
gram generates a feedback letter that is highly tailored to
the individual's responses.
The efficacy of our tailored feedback was evaluated as an
adjunct to telephone counselling (via the national Quit-
line) in a randomised trial of 1508 participants [14].
Results showed that at the 6-month follow-up, for the
majority who were smokers at baseline (n = 1164), this
intervention significantly increased 1-month prolonged
abstinence rates from 11.3% in the control group to
16.4% in the intervention group (p < 0.02). These find-
ings are consistent with previous studies, which have
demonstrated a positive effect of individually tailored
printed self-help material on smoking cessation [15-17],
and suggest that these effects may increase with time [9],
in contrast to clinic based treatments which have large
effects immediately post treatment but decline over time
[18,19]. A Cochrane review [20] reported on a meta-anal-
ysis of seventeen trials using materials tailored to the char-
acteristics of individual smokers. While part of the effect
could be due to the additional contact or assessment
required to obtain individual data, there is evidence that
tailored materials increase quit rates over and above
standard materials and untailored materials (OR 1.42,
95% CI 1.26 – 1.61).
Two exceptions to this are recent UK general practice
based studies that failed to demonstrate an increase in ces-
sation rates for tailored feedback compared with an untai-
lored letter [21] or with standard self help literature [22].
Both were based on the transtheoretical model (TTM)
[23] which has serious conceptual and measurement
problems [24,25]. The materials used in the study by Len-
nox and colleagues were also lacking in the depth of indi-
vidual tailoring and in practical advice on how to stop
smoking [26]. Our tailored intervention differs from that
used in these two studies. Development of our interven-
tion was informed by evidence from the smoking cessa-
tion literature, using specific concepts from different
theoretical models of behaviour change that have been
shown to be relevant to change. It aims to change the cog-
nitive determinants of smoking and smoking cessation,
by addressing beliefs and expectations, and attitudinal
ambivalence towards quitting, by enhancing perceived
self-efficacy and re-evaluating the social environment.
Theoretically, this is consistent with a number of social
cognition models that have been applied to understand-Trials 2008, 9:23 http://www.trialsjournal.com/content/9/1/23
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ing smoking cessation. Previous research [15] has sug-
gested the importance of tailoring to specific theoretical
constructs. Matching advice to stage of readiness is com-
mon in many of the existing computerised programs.
However, the use of one model exclusively, e.g. the tran-
stheoretical or "stages of change" model (TTM) [23], to
drive the tailoring does not allow for individual variation
from that pattern of change or in the sequence of move-
ment along the continuum. Stronger tailoring programs
can be produced by using multiple theories to inform the
tailoring process [27]. In addition to this strong theoreti-
cal base, our system is based on empirical findings (e.g. on
predictors of quit attempts and success). By identifying
specific factors that influence behaviour and decisions, we
offer information to encourage individuals to bring about
the desired cognitive states or behaviour for successful
quitting. Moreover, the feedback reports were developed
in consultation with smoking cessation counsellors and
include conventional wisdom (e.g. the importance of set-
ting a quit date). Our tailored feedback reports are there-
fore more psychologically detailed than those used
previously in UK studies. The format resembles a personal
letter, and differs from the promotional leaflet style used
in other studies.
Since our previous study with the Quitline, [14] we have
done extensive work to develop the intervention, consist-
ent with the MRC Framework for the Development and
Evaluation of Complex Interventions [28].
Smoking cessation literature has been criticised in the past
for being written at a level beyond the literacy skills of
many smokers [29], leading to higher levels of education
associated with the use of self-help materials [16]. Results
from our previous study [14] suggest that the tailored
feedback may be as effective among more deprived smok-
ers as in the less deprived. Extensive work on the develop-
ment of the intervention, in consultation with literacy
experts, has modified the questionnaire and tailored the
format and content of the advice to different educational
levels. Focus groups engaged users (i.e. smokers) in
exploring the acceptability and suitability of the materials,
and their suggestions incorporated into the modifica-
tions.
In addition, the acceptability and feasibility of the deliv-
ery of this modified feedback in general practice using a
proactive recruitment strategy has been assessed in a pilot
trial [30]. Questionnaires were sent to a random sample of
200 smokers identified from GP records from each of four
practices. Results indicate that a 10% response rate can be
achieved with one mailing. There are strategies that can be
used to increase response rates [31], and by using some of
these strategies (e.g. a reminder with a second copy of the
questionnaire, a more attractive questionnaire with the
use of colour) we estimate that the response rate could be
increased to 15%.
The results of the pilot trial also indicate that a high pro-
portion of the respondents are not planning to quit in the
next six months [30]. It is essential that we develop meth-
ods to engage these smokers in cognitive change to
encourage modification of attitudes and beliefs to pro-
mote cessation activity in this population group. To
address this we have incorporated cognitive strategies and
motivational interviewing techniques which are generally
more appropriate for smokers not ready to quit [32], into
the tailored interventions in varying degrees to suit the
motivation of the smoker. In our previous study of callers
to the Quitline [14], participants received a single feed-
back letter. However, this system can store data, to be used
at a later date in combination with new information pro-
vided by the smoker. In the present study the data is being
used in this way to expand the intervention by including
a second assessment and letter. Multiple tailoring has
been shown to be more effective than single tailoring in
promoting cognitive change in smokers with low readi-
ness to quit [33].
The aim of this study is to test the hypothesis that person-
ally tailored feedback reports, based on an assessment of
individual needs and tailored to levels of reading ability,
sent to smokers identified from general practitioners lists
with varying levels of motivation and readiness to quit,
will increase quit rates and quitting activity over and
above that found with standard self help and usual care
received from the practice. The study objectives are 1) to
compare the effectiveness of sending personalised compu-
ter tailored feedback reports to smokers with sending
standard self-help materials 2) to explore the effectiveness
of tailored feedback reports by socio-economic status to
determine their effect in more deprived groups 3) to deter-
mine the characteristics of smokers who are prompted to
change their behaviour after receiving tailored feedback
reports.
Methods
Design of the study
The study is a randomised controlled trial of cigarette
smokers identified from GP records and sent a question-
naire. Smokers returning the questionnaire are randomly
allocated to a Control Group, to receive standard help, or
to an Intervention Group to receive tailored feedback
reports. The trial is conducted as a collaboration between
UCL and University of Cambridge, and is co-ordinated
from UCL. The study has been reviewed and approved by
the Northern and Yorkshire MREC, and has received R&D
approval from all participating PCTs.Trials 2008, 9:23 http://www.trialsjournal.com/content/9/1/23
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The research has substantial potential to benefit partici-
pants, by improving health through a positive change of
lifestyle. The information leaflet also informs participants
that while there is no guarantee that the information they
receive will help, they may find that they learn more about
themselves by answering the questions. The aim of the
intervention is to help participants to stop smoking, it is
therefore unlikely that there will be any adverse effects.
However, anyone experiencing distress as a result of the
assessment or intervention, is advised to discuss it with
their GP or a counsellor.
Participants and recruitment
The MRC General Practice Research Framework (GPRF) is
a network of 1100 practices scattered throughout the UK.
We are recruiting 100 GPRF practices, selected to represent
high and low socio-economic areas to maximise the gen-
eralisability of the results. Practices generally identify 13%
to 22% of their patients as smokers, depending on the
characteristics of the patient population, and the accuracy
and completeness of the records [30]. A medium sized
practice with 6000 to 7000 patients, would therefore iden-
tify between 780 and 1540 smokers. A sample, randomly
selected using the practice computer systems, of 500
smokers from each practice (a total of 50000) are sent an
assessment questionnaire, together with a covering letter
from their GP. Using proactive recruitment to contact
smokers directly and invite them to participate, we aim to
secure a return rate in the order 15%, from 2 mailings
based on previous studies [17,21], and on our pilot study
to secure 7250 participants over a 12 months period from
August 2007 to July 2008.
Inclusion/exclusion criteria
All current cigarette smokers aged 18 to 65 able to read
English are eligible for inclusion in the study. Exclusion
criteria are minimal because the aim is to recruit all smok-
ers. However, any patients selected who are considered by
the GP to be unsuitable for the project, e.g. people with
severe mental impairment or severely or terminally ill, are
excluded.
Randomization
Those willing to be contacted for future assessment return
the completed questionnaire, together with a signed con-
sent form, to the research team at University College Lon-
don. Randomisation is at the level of the study
participants. Upon receipt of the completed questionnaire
eligible participants are randomly assigned to one of the
two conditions, according to an externally constructed
randomisation plan. The general practices represent a
clustering variable and to reduce any confounding by
practice we are using block randomisation, using blocks
of eight (within which the order of assignment will be ran-
dom), within each practice to allocate patients to each
condition to closely balance the numbers. In a large trial
such as this, we expect the conditions to be balanced on
important predictive factors such as dependence.
However, any imbalances will be controlled for in the sta-
tistical analysis. While it is not possible to blind partici-
pants to the receipt of a feedback letter, in order to ensure
that the researchers in all cases are blind to the allocation
of the participant, the feedback is generated by a service
administrator. To avoid bias in the outcome assessment,
when conducting follow-up interviews by telephone for
non-responders the interviewer will be blinded to the
allocation of the respondent.
Trial interventions
Participants are sent materials according to their randomi-
sation, immediately after returning the questionnaire.
Participants allocated to the Control Group are sent stand-
ard non-tailored information (the NHS 'SMOKEFREE'
booklet), as well as receiving the usual care offered by
their general practice. To eliminate any variation in the
care offered, usual care is defined from the results of the
pilot study, and we attempt to ensure that all recruited
practices offer the same protocol. Participants allocated to
the Intervention Group are sent a computer-tailored feed-
back report based on the information obtained at base-
line, in addition to the standard non-tailored information
and receipt of the usual care offered by their general prac-
tice. The Intervention Group are also sent an additional
assessment to generate a further personal progress report
one-month after the baseline.
Materials
The baseline assessment questionnaire (SBQ) assesses
demographic characteristics (including educational and
literacy level), intention to quit, motivation, dependence,
previous quit attempts, perceived advantages and disad-
vantages of quitting, self-efficacy and social environment.
The baseline data are scanned and entered using FORMIC
data capture software, simultaneously creating an SPSS
file containing data for analysis, and a data file for produc-
ing feedback letters. A computer program temporarily
combines these data with the personal data of participants
allocated to the Intervention Group, selecting the correct
messages from the message library to produce a feedback
report. Once the report is produced the file is deleted, in
accordance with the Data Protection Act. Participants are
informed of this possible use of the data.
Time schedule
Participants in the Control group receive the standard self-
help immediately after returning the questionnaire. Par-
ticipants in the Intervention group also receive the addi-
tional help in the form of a personal feedback letter
immediately after returning the questionnaire, and a fur-Trials 2008, 9:23 http://www.trialsjournal.com/content/9/1/23
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ther one-month assessment for generating a personal
progress report. The time schedule for the mailing of
assessment and follow-up questionnaires, and interven-
tion materials is presented in Table 1.
Outcome measures
Outcomes are to be measured by postal questionnaire.
Non-respondents to questionnaires will receive one
postal reminder. Non-respondents to the reminder will be
contacted by telephone. In order to estimate the accuracy
of self-reports, a random sample of 20% of the partici-
pants who report abstinence will have their status vali-
dated by salivary cotinine sample, obtained by post.
Long term abstinence has been thought of as the gold
standard for evaluating smoking cessation interventions,
but has been criticized as failing to measure other possible
benefits of treatment, such as repeated quit attempts and
shorter periods of abstinence [34]. Recent recommenda-
tions suggest the use of less stringent criteria of 4-week or
7-day abstinence [35]. Cessation-induction trials test a
treatment to prompt cessation among all smokers, includ-
ing those with low motivation [36], it is important there-
fore in such trials to measure cognitive change, which can
lead to quit attempts, short periods of abstinence, and
eventual prolonged abstinence. Six months is widely rec-
ommended as the minimum length of follow-up in such
trials, and accepted by the Cochrane reviews on smoking
cessation.
The Primary Outcome Measure is Prolonged abstinence
for 1 month and for 3 months at the 6-month follow-up.
Secondary Measures are 24 hr and 7 day point-prevalence
abstinence, quit attempts, changes in motivation and
intention to quit, and in cognitions measured at baseline,
use of NRT or Zyban, and any contact with advice services
or health professionals (group, clinic, telephone, or face-
to-face), use of NHS resources and other smoking cessa-
tion aids for economic analysis.
Process measures are adherence to advice, perceptions of
the feedback reports, perceived personal relevance of the
feedback reports.
Performance figures against target figures set by PCTs
before and after the intervention will be obtained from
General Practices as indicators of activity.
Data analysis
Sample size and power calculations
Spontaneous cessation is difficult to estimate, but popula-
tion cessation rates suggest that it is between 0.5% and 3%
[3]. Studies aimed exclusively at self-quitting unaided
attempts have found 6 month abstinent rates of 3% [37]
and 4.9% [38]. Lancaster and Stead, in a review of thirteen
trials comparing standard self-help with no help [20]
found an average 6 month quit rate in the control groups
of 5%, with the pooled intervention rate slightly higher.
Based on these figures we might expect a 3 month absti-
nence rate in a control group receiving standard materials
to be at the upper limit of estimates of spontaneous long-
term abstinence in the population (i.e. 3%).
The Cochrane review [20] of seventeen randomised trials
of smoking cessation found that individually tailored
materials were more effective than standard and untai-
lored materials (OR 1.42, 95% CI 1.26 – 1.61) where the
main outcome was abstinence from smoking after at least
6 months follow-up. The authors report different odds
ratios for studies grouped by type, and the range of esti-
mates demonstrate the uncertainty in this area and the
need for further research. A range of possible effect sizes
that could be used to power the trial are presented in Table
2. To carry out the trial within the resources available, we
aim to recruit a sample of 7250. While a sample of this
size does not give adequate power at the lower limit, it
will give the minimum power required to detect a differ-
ence using the midpoint of the range of odds ratios,
assuming a two-tailed test and alpha of 0.05 [39].
Attrition and Compliance
Based on our previous studies, we expect approximately
20–25% attrition [14,40]. For the main analysis partici-
Table 1: Time schedule for mailing of assessment and follow -up questionnaires and intervention materials
T1 = Baseline T2 = 1 month T3 = 6 months
Baseline questionnaire (SBQ) and GP covering letter 
sent from practice and returned to research team.
One-month assessment for generating a 
progress report, sent by research staff 
to Intervention Group participants re-
assessing baseline measures.
Follow-up questionnaire sent by research team 
to all participants assessing:
Control and Intervention materials dispatched 
immediately.
Primary outcome
Secondary outcome
Process measuresTrials 2008, 9:23 http://www.trialsjournal.com/content/9/1/23
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pants who cannot be contacted at follow-up will be
assumed to be smoking (intention-to-treat analysis). Pre-
vious studies have found that the number of participants
in the intervention group who recalled receiving a per-
sonal letter at the 6-month follow-up ranged from 64%
[21] to 89% [17]. Analysis of the treatment effect will be
based on the whole sample.
Planned analyses
Chi-squared tests will compare binary outcomes between
the intervention and control groups (e.g. for prolonged
abstinence of 4 weeks), with logistic regression to take
into account any chance imbalance in important baseline
characteristics between the groups. Continuous variables
(e.g. cognitive changes) will be compared with the two-
sample t-test, with multiple regression to account for
other important characteristics. Odds ratios and 95% con-
fidence intervals for differences in means or medians (as
appropriate) will be quoted.
To address drop-out, the primary analysis will assume that
non-responders continue to smoke. Multiple imputation
methods will be used as a sensitivity analysis, where pre-
dictors of drop-out will be used to impute likely outcomes
(SOLAS software).
Because benefits of interventions may differ by general
practice, and patients within practices may demonstrate
more similarity in their outcome than patients in different
practices, multi-level models will be applied to take into
account general practice effects (MLwiN software).
Participants will be categorised by socio-economic status,
social deprivation and different educational level to
explore the effectiveness of the intervention in these
groups.
Economic and Quality of Life issues
The incremental cost-effectiveness of the individual feed-
back compared to the control condition will be assessed
from the NHS perspective in line with methods recom-
mended by NICE [41]. The costs of administration and
generation of the feedback will be estimated along with
the basic care package from the application of the trial
protocols in the different practice settings. The follow-up
questionnaire will ask participants about their use of NHS
resources, additional primary care appointments or pre-
scriptions and use of specialist smoking cessation services,
and other cessation aids. The data on use from these ques-
tionnaires will be combined with national estimates of
their long run marginal costs from a variety of sources. Six
month quit rate (adjusted for cotinine validation) will be
used with appropriate epidemiological and economic
modelling techniques to estimate the potential quality of
life years gained and future savings in smoking related
health care costs. The primary analysis with extensive sen-
sitivity analysis including bootstrapping and the use of
cost effectiveness acceptability curves will be to assess the
cost effectiveness of the intervention compared to the con-
trol. However, the data from the trial will also be used to
model the overall immediate costs of implementing the
intervention in GP practices (including any increased use
of other smoking related services) for different types of
practices (e.g. in high and low deprived areas) and for
England as a whole. Modelling will also be undertaken of
the population levels effects on the health of the popula-
tion and the NHS (including allowance for future savings
in NHS costs) and how this intervention may interact with
other policy initiatives.
In accordance with NICE technical appraisal guidelines
[41], we are using EQ-5D at baseline and at follow-up to
investigate short-term quality of life changes. Quality and
quantity of life issues will be addressed as part of further
modelling of longer-term improvement effects.
Consumer Involvement
Small groups of smokers recruited via the Quitline com-
mented on the original questionnaire and feedback letter,
which were modified accordingly. The smoking cessation
counsellors at the Quitline also provided input. Ongoing
research using Focus Group discussions with smokers
have explored consumers' views on the acceptability of
this approach to encourage and support smoking cessa-
tion. Follow-up questionnaires sent to all participants in
the study will evaluate users' perception of the materials.
Participants will have the opportunity to request a report
Table 2: Effect sizes and power for different size samples
OR % increase in cessation rate Sample % power
Lower 1.26 3.75 4350 25
5800 33
7250 40
8700 47
Middle 1.42 4.21 4350 54
5800 67
7250 77
8700 84
Upper 1.61 4.74 4350 83
5800 92
7250 97
8700 99
Assuming a cessation rate of 3% in the control group, with the 
relative increases in the proportion who report continuous 
abstinence of 3 months or more at a 6-month follow-up in the 
intervention group, applying the lower, middle, and upper odds ratios 
of 1.26, 1.42, and 1.61 (and assuming that participants who cannot be 
contacted at follow up are still smoking)Trials 2008, 9:23 http://www.trialsjournal.com/content/9/1/23
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of the results. A lay summary will be prepared and sent to
all participants requesting one.
Discussion
In the UK there are 450 new smokers every day [42]. At
this rate of recruitment to the smoking population, there
is an urgent need to develop and deliver cost-effective
interventions to the bulk of the population, rather than to
the minority of dependent smokers who seek specialized
help [43].
It is important to offer a range of interventions that appeal
to different individual needs and preferences [44]. Com-
puter tailored personal feedback, adapted to reading lev-
els and motivation to quit, is a simple and inexpensive
intervention which could be widely replicated and deliv-
ered cost effectively to a large proportion of the smoking
population. The current portfolio of NHS services does
not include a highly tailored approach for smokers who
do not wish to attend clinics or have face-to-face counsel-
ling.
Reaching and changing the behaviour of smokers, partic-
ularly heavily dependent smokers and those from lower
socio-economic groups is a challenging task, and the
effect of any intervention likely to be small. However, con-
trary to common assumptions, the proportion of hardcore
smokers (defined by cigarette consumption and time
from waking to first cigarette), forms a lower proportion
of all smokers than in 1996 [45]. Although, the prevalence
of smoking by socio-economic group remains unchanged,
there are no differences by socio-economic group or by
cigarette consumption in intentions and desire to quit and
in attempts to quit [45], suggesting that these harder to
reach groups will be as receptive to help and encourage-
ment as higher socio-economic groups and less depend-
ent smokers. Furthermore, a modest success rate could
have a large effect on public health given its recruitment
potential, and make a valuable contribution to lowering
smoking prevalence.
Brief advice from GPs has been shown to increase quit
rates [46], and this method enables the standardised col-
lection of relevant information from smokers by practice
nurses or other health professionals, and could offer an
efficient tool to integrate smoking cessation counselling
into a busy primary care practice. The degree of uptake by
GPs of this intervention is an important issue requiring
research in its own right. However, feedback from general
practices will inform the degree of uptake as well as rea-
sons for agreeing or refusing to take part in the study, and
also identify any potential barriers to the implementation
of the intervention. The provision of this option to smok-
ers in primary care could complement existing services,
and work synergistically with other measures to produce
more quitters and reduce the prevalence of smoking in the
UK. This is also an intervention that would fit into the
broader scope of tobacco control, by prompting more quit
attempts, and increasing referrals to specialised services.
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